AP
SGNT

Advisors Preferred’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Advisors Preferred’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,367
Closed -$31.8K – 309
2015
Q1 		$31.8K Sell
1,367
-6,137
-82% -$162K 0.02% 166
2014
Q4 		$188K Buy
7,504
+5,451
+266% +$160K 0.09% 135
2014
Q3 		$63.8K Buy
+2,053
New +$55.6K 0.04% 112

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Advisors Preferred's SGNT Position: Q2 2015 in Review

Advisors Preferred sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2015, closing a stake of 1,367 shares — an estimated $31.8K sold.

Advisors Preferred first reported a position in SGNT in Q3 2014 and held it in 3 quarters. The position peaked at $188K in Q4 2014. 136 funds tracked by Wall St. Rank hold SGNT as of Q2 2015.

  • Advisors Preferred reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Advisors Preferred sold 1,367 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $31.8K.
  • Advisors Preferred first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • Advisors Preferred's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $188K in Q4 2014.
  • 136 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Advisors Preferred's 13F filing for Q2 2015, filed 31 Jul 2015.